PMA P190031S012

Device
VENTANA HER2 Dual ISH DNA Probe Cocktail
Applicant
Ventana Medical Systems, Inc.
PMA number
P190031
Supplement
S012
Product code
NYQ
Decision date
2025-05-16
Classification
Pathology
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Approval order statement
Approval for the migration of the VENTANA HER2 Dual ISH DNA Probe Cocktail from BenchMark ULTRA to BenchMark ULTRA PLUS instrument

Current openFDA PMA Record#

Device
VENTANA HER2 Dual ISH DNA Probe Cocktail
Applicant
Ventana Medical Systems, Inc.
PMA number
P190031
Supplement
S012
Product code
NYQ
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Decision date
2025-05-16
Decision code
APPR
Date received
2024-09-26
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
Approval for the migration of the VENTANA HER2 Dual ISH DNA Probe Cocktail from BenchMark ULTRA to BenchMark ULTRA PLUS instrument